Cargo loading within ferritin nanocages in preparation for tumor-targeted delivery

• Published in: Nature protocols Vol. 16; no. 10; pp. 4878 - 4896
• Main Authors: Zhang, Jianlin, Cheng, Dengfeng, He, Jiuyang, Hong, Juanji, Yuan, Chang, Liang, Minmin
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 01-10-2021; Nature Publishing Group
• Subjects: 631/1647/350/2093; 631/61/350; 631/67/1059/153; 639/925/357/354; Analytical Chemistry; Antineoplastic Agents - administration & dosage; Antineoplastic Agents - therapeutic use; Antineoplastic drugs; Antitumor agents; Biological Techniques; Biomedical and Life Sciences; Chains; Chemical compounds; Computational Biology/Bioinformatics; Diagnostic systems; Doxorubicin; Doxorubicin - administration & dosage; Doxorubicin - chemistry; Drug delivery; Drug delivery systems; Drug Delivery Systems - methods; Drug therapy; Drugs; Ferritin; Ferritins - chemistry; Fluorescence; Fluorophores; Gadolinium; Genetic engineering; Health aspects; Humans; Immunogenicity; Life Sciences; Metal Nanoparticles - chemistry; Methods; Microarrays; Molecular targeted therapy; Nanoparticles; Neoplasms; Organic Chemistry; Protocol; Radioisotopes; Storage proteins; Tumors; Vehicles; China
• ISSN: 1754-2189; 1750-2799; 1750-2799
• DOI: 10.1038/s41596-021-00602-5

Ferritins are spherical iron storage proteins within cells, composed of 24 subunits of two types, heavy-chain ferritin (HFn) and light-chain ferritin. Ferritins auto-assemble naturally into hollow nanocages with an outer diameter of 12 nm and an interior cavity 8 nm in diameter. Since the intrinsic tumor-targeting property of human HFn was first reported in 2012, HFn has been extensively explored for tumor-targeted delivery of anticancer drugs and diagnostic molecules, including radioisotopes and fluorophores, as well as inorganic nanoparticles (NPs) and chemotherapeutic drugs. This protocol provides four detailed procedures describing how to load four types of cargoes within HFn nanocages that are capable of accurately controlling cargo loading: synthesis of inorganic metal nanoparticles within the cavity of a wild-type human HFn nanocage (Procedure 1, requires ~5 h); loading of doxorubicin into the cavity of a wild-type human HFn nanocage (Procedure 2, requires ~3 d); loading Gd
3+
into the cavity of a genetically engineered human HFn nanocage (Procedure 3, requires ~20 h); and loading
64
Cu
2+
radioisotope into the cavity of a genetically engineered human HFn nanocage (Procedure 4, requires ~3 h). Subsequent use of these HFn-based formulations is advantageous as they have intrinsic tumor-targeting capability and lack immunogenicity. Human HFn generated as described in this protocol can therefore be used to deliver therapeutic drugs and diagnostic signals as multifunctional nanomedicines.
This protocol describes how to load inorganic metal nanoparticles, drugs or radioisotopes into hollow nanocages composed of heavy-chain ferritin. The resulting formulations have intrinsic tumor-targeting capability and lack immunogenicity in vivo.